MAUDE Adverse Event Report: LUTONIX, INC LUTONIX 035AV DRUG COATED PTA DILATION CATHETER; DRUG COATED BALLOON PTA CATHETER

Model Number	9010
Medical Device Problem Code	Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes	Aneurysm (1708); Chest Pain (1776); Restenosis (4576); Swelling/ Edema (4577)
Date of Event	08/09/2023
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
H10: as the lot number for the device was provided, a review of the device history records will be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.H10: d4 (expiration date: 10/2023).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
Event or Problem Description
It was reported through the results of a clinical trial that two months and twenty-five days post index procedure using a drug-coated balloon catheter in the cephalic vein arch, the subject had an adverse event of low access flow with occurrence of restenosis of the target lesion and required an arteriovenous access circuit reintervention.It was further reported that the target lesion was in the upper arm with eighty percent initial stenosis and nineteen percent final residual stenosis.Reportedly, standard percutaneous transluminal angioplasty was used for treatment.The re-intervention was successful, and the outcome of the adverse event was resolved.The current status of the patient is unknown.
Event or Problem Description
It was reported through the results of a clinical trial that two months and twenty-five days post index procedure using a drug-coated balloon catheter in the cephalic vein arch, the subject had an adverse event of low access flow due to stenosis of cephalic vein with occurrence of restenosis of the target lesion and required an arteriovenous access circuit reintervention.It was further reported that the target lesion was in the upper arm with eighty percent initial stenosis and nineteen percent final residual stenosis.Reportedly, standard percutaneous transluminal angioplasty was used for treatment.The re-intervention was successful, and the outcome of the adverse event was resolved.The current status of the patient is unknown.
Additional Manufacturer Narrative
H10: manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: the physical device was not returned for evaluation.No photos were provided for review.Therefore, the investigation is inconclusive for the reported failure as no objective evidence was provided for review.Based upon the available information, the definitive root cause is unknown.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.H10: b5, d4 (expiration date: 10/2023), g3, h6 (method) h11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
Additional Manufacturer Narrative
H11: manufacturing review: the device history records have been reviewed and this lot met all release criteria.Investigation summary: the physical device was not returned for evaluation.No photos were provided for review.Therefore, the investigation is inconclusive for the reported failure as no objective evidence was provided for review.Based upon the available information, the definitive root cause is unknown.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.B5, d4 (medical device expiration date, unique identifier (udi) #), g3, h6 (patient, component, method).Section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
Event or Problem Description
It was reported through the results of a clinical trial that two months and twenty-five days post an index procedure using a drug-coated balloon catheter in the cephalic vein arch, the subject had an adverse event of low access flow due to stenosis of cephalic vein with occurrence of restenosis of the target lesion and required an arteriovenous access circuit reintervention.It was further reported that the target lesion was in the upper arm with eighty percent initial stenosis and nineteen percent final residual stenosis.Reportedly, standard percutaneous transluminal angioplasty was used for treatment.It was further reported that one year, nine months and nineteen days post an index procedure, the subject had an another adverse event of left upper extremity swelling due to fistula with aneurysmal segment in the cannulating area with proximal stenosis 50% and cephalic arch intent stenosis.Reportedly, the adverse event was not related to study device and study procedure but possibly related to av access circuit.Furthermore, a standard pta was used in re-intervention on the target lesion on subclavian vein with initial stenosis of 50% and final residual stenosis of 29%.Reportedly, the re-intervention was successful, and the outcome of the adverse event was resolved.The current status of the patient was unknown.
Additional Manufacturer Narrative
H11: manufacturing review: the device history records have been reviewed and this lot met all release criteria.Investigation summary: the physical device was not returned for evaluation.No photos were provided for review.Therefore, the investigation is inconclusive for the reported failure as no objective evidence was provided for review.Based upon the available information, the definitive root cause is unknown.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.B5, g3, h6 (patient).Section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
Event or Problem Description
It was reported through the results of a clinical trial that two months and twenty-five days post index procedure using a drug-coated balloon catheter in the cephalic vein arch, the subject had an adverse event of low access flow due to stenosis of cephalic vein with occurrence of restenosis of the target lesion and required an arteriovenous access circuit reintervention.It was further reported that the target lesion was in the upper arm with eighty percent initial stenosis and nineteen percent final residual stenosis.Reportedly, standard percutaneous transluminal angioplasty was used for treatment.It was further reported that approximately one year nine months and nineteen days post index procedure, the subject had an another adverse event of left upper extremity swelling due to fistula with stenosis segment in the cannulating area with proximal stenosis 50% and cephalic arch intent stenosis.Reportedly, the adverse event was not related to study device and study procedure but possibly related to av access circuit.Furthermore, a standard pta was used in re-intervention on the target lesion on subclavian vein with initial stenosis of 50% and final residual stenosis of 29%.Reportedly, the re-intervention was successful, and the outcome of the adverse event was resolved.It was further reported that the patient had an adverse event of chest pain which eventually resulted in the death of the patient.However, the cause of death was not provided.The adverse event, "death" was not related to the device, procedure and av access circuit.

• Brand Name: LUTONIX 035AV DRUG COATED PTA DILATION CATHETER
• Common Device Name: DRUG COATED BALLOON PTA CATHETER
• Manufacturer (Section D): LUTONIX, INC; 9409 science center dr; new hope MN 55428
• Manufacturer (Section G): C.R. BARD, INC. (GFO); 289 bay road; queensbury 12804
• Manufacturer Contact: brett curtice ; 800 w. rio salado pkwy; tempe, AZ 85281 ; 4803032689
• MDR Report Key: 18214063
• Report Number: 3006513822-2023-00045
• Device Sequence Number: 5671830
• Product Code: PRC
• UDI-Device Identifier: 00801741135460
• UDI-Public: (01)00801741135460(11)221118(17)231010(10)GFGV2261
• Combination Product (Y/N): N
• Initial Reporter State: MI
• Initial Reporter Country: US
• PMA/510(K) Number: P170003
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Reporter Type: Manufacturer
• Report Source: Other,Study
• Initial Reporter Occupation: Physician
• Type of Report: Initial,Followup,Followup,Followup
• Report Date (Section B): 12/10/2025

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Expiration Date: 10/10/2023
• Device Model Number: 9010
• Device Catalogue Number: LX3575860V
• Device Lot Number: GFGV2261
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Type of Report(Section G): Follow-Up
• Initial Date Received by Manufacturer: 11/03/2023
• Supplement Date Received by Manufacturer: 12/19/2023; 06/18/2025; 01/02/2026
• Initial Report FDA Received Date: 11/28/2023
• Supplement Report FDA Received Date: 12/21/2023; 06/20/2025; 01/08/2026
• Was Device Evaluated by Manufacturer? (Y/N): No
• Date Device Manufactured: 11/18/2022
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Age: 73 YR
• Patient Sex: Male
• Patient Weight: 88 KG
• Patient Ethnicity: Non Hispanic
• Patient Race: White